Spironolactone Cost in Tennessee (2026): Cash Price, Insurance, and Savings Options

Spironolactone (brand name Aldactone) is an oral aldosterone antagonist and potassium-sparing diuretic. The FDA approved it for heart failure, hypertension, edema, and primary hyperaldosteronism. Its use for hormonal acne and hirsutism in women is off-label, meaning it is prescribed based on clinical experience and published studies rather than an FDA-reviewed acne indication. Generic spironolactone is one of the least expensive prescription options used for acne, and its cash price at most U.S. pharmacies, including Tennessee locations, is commonly in the low double digits per month rather than the branded list price. Tennessee Medicaid (TennCare) has historically limited coverage to the drug's approved cardiovascular indications rather than acne, though formulary details change and should be confirmed directly with TennCare before a patient relies on this for planning.

That paragraph is the core of what this page can responsibly say without a live pricing feed or a confirmed current TennCare formulary document. Everything below expands on it, and separates what is stable (FDA status, drug class, general regulatory framework) from what changes month to month (specific dollar amounts, insurer tiering, discount card pricing).

What spironolactone is, and what it is not approved for

Spironolactone blocks the hormone aldosterone and has mild anti-androgen effects, which is why some prescribers use it off-label for adult women with hormonal acne, particularly jawline and lower-face patterns tied to the menstrual cycle. The FDA-approved indications remain cardiovascular and renal: heart failure, hypertension, edema from conditions like cirrhosis or nephrotic syndrome, and primary hyperaldosteronism (FDA drug approval record). Acne is not listed. This distinction matters for insurance and Medicaid coverage, because payers frequently tie coverage decisions to the diagnosis code submitted with a claim, and a diagnosis of acne (rather than hypertension or heart failure) can trigger a different coverage outcome even for the identical pill.

Cash-pay pricing: what is reasonably well established, and what needs verification

Generic spironolactone is widely regarded as an inexpensive prescription drug, and 30-day supplies at major U.S. retail chains, including those operating in Tennessee, are commonly reported in the range of roughly $5 to $25 depending on pharmacy, dose, and whether a discount card is used. The branded product, Aldactone, carries a much higher list price, though generic substitution is standard practice at pharmacies unless a prescriber specifically blocks it.

This article does not have a verified, dated Tennessee-specific price feed, so any single dollar figure quoted here should be treated as illustrative rather than current fact. Pharmacy pricing changes by location, wholesaler contract, and month. Before filling a prescription, confirm the current price directly with the pharmacy or through a discount-card app, and compare that number against your insurance copay if you have coverage. For patients on a high-deductible plan, it is common for the cash price with a discount card to be lower than the insurance-negotiated copay, which is worth checking each time rather than assuming.

Discount programs such as GoodRx, SingleCare, RxSaver, and mail-order services like Cost Plus Drugs are widely used for generic spironolactone nationally. Specific current prices from these programs are not verified in this draft and should be checked at the time of use rather than quoted as fixed numbers.

Does TennCare (Tennessee Medicaid) cover spironolactone for acne?

TennCare's formulary structure, like most state Medicaid programs, generally covers spironolactone for its FDA-approved cardiovascular and renal indications. Coverage for off-label dermatologic use, such as acne or hirsutism, typically requires either a compendia-supported exception or a prior authorization demonstrating medical necessity, and approval is not guaranteed. This article did not have access to a current, dated TennCare preferred drug list to confirm exact prior-authorization criteria or approval rates, so readers should check the current TennCare formulary directly (TennCare) or ask their prescriber's office to run a coverage check before assuming a particular outcome.

One point worth understanding: if a patient carries a diagnosis that is separately covered, such as hypertension or heart failure, and also happens to benefit from spironolactone's acne effect, coverage may follow the primary covered diagnosis rather than the off-label one. This is a legitimate billing practice when the patient genuinely has both conditions, not a workaround to be used when the primary diagnosis is not actually present.

Commercial insurance in Tennessee

Generic spironolactone is a common, low-cost generic drug, and most commercial formularies place it in a low copay tier. Coverage specifics, including whether an acne diagnosis code triggers a rejection or requires a different diagnosis on the claim, vary by plan and are not something this article can state with certainty for every Tennessee insurer. Broad statements about "179 plan options across 95 counties" or similarly precise marketplace statistics require a current, dated source and are not included here because they could not be verified against the material available for this draft. If plan-specific detail matters for a coverage decision, check the specific plan's formulary document or call member services, since these details change with each plan year.

The Affordable Care Act requires marketplace plans to cover prescription drugs as an essential health benefit category, and potassium-sparing diuretics are a class commonly represented on qualified health plan formularies, but the exact class requirements and any given plan's specific formulary should be confirmed against that plan's current documents or CMS resources (CMS) rather than assumed from a general statement.

Compounded spironolactone in Tennessee

Compounded medications, including topical spironolactone preparations, are legally available through 503A compounding pharmacies when prepared for an individual patient under a valid prescription. The FDA distinguishes 503A pharmacies (patient-specific compounding, regulated primarily at the state board of pharmacy level) from 503B outsourcing facilities (larger-scale compounding without a patient-specific prescription requirement, subject to closer FDA oversight and current good manufacturing practice standards) (FDA compounding Q&A; FDA cGMP overview).

Topical spironolactone is sometimes used by patients hoping to reduce systemic exposure and side effects such as elevated potassium, breast tenderness, or menstrual changes that can occur with oral dosing. Compounded topical spironolactone has not gone through the same large-scale randomized trial process as oral dosing, and its comparative effectiveness is not established at the level of evidence available for oral therapy. A prescriber can discuss whether a compounded option is appropriate for a given patient, but it should not be assumed to be equivalent to oral dosing in either effect or cost.

Compounded formulations are typically priced differently from standard generic tablets, often higher, because they are prepared individually rather than mass-manufactured. Specific current price ranges for Tennessee 503A pharmacies were not available for verification in this draft.

Telehealth prescribing

Spironolactone is not a federally controlled substance, so it does not carry the same telehealth prescribing restrictions that apply to controlled medications. Licensed Tennessee prescribers, including those practicing through telehealth platforms, can prescribe it after an appropriate clinical evaluation, which for a new patient with acne typically includes a history, photos or visual assessment, and a discussion of risks including the recommendation for baseline lab monitoring. Practices vary in whether baseline labs are required before the very first prescription versus scheduled shortly after starting; this is a site-specific clinical judgment rather than a fixed rule, and patients should ask their specific prescriber what their protocol requires.

Monitoring and the true cost of therapy

The medication cost is only part of the total cost of spironolactone therapy. Baseline and periodic monitoring of serum potassium and kidney function (creatinine) is standard clinical practice, particularly important for patients also taking ACE inhibitors, ARBs, potassium supplements, or NSAIDs regularly, and for anyone with underlying kidney disease. Hyperkalemia risk is generally considered low in young, healthy patients without kidney impairment, which describes much of the population using spironolactone for acne, but monitoring is still standard of care rather than optional in most prescribing protocols. Exact monitoring intervals vary by prescriber and by guideline source; if you want the specific interval your prescriber is following, ask them directly rather than assuming a single national standard applies uniformly.

Basic metabolic panel lab costs vary widely by whether the patient has insurance, uses a cash-pay lab service, or goes through a hospital outpatient lab, and this draft does not have a verified current Tennessee-specific lab price to cite. A reasonable planning approach is to ask the ordering clinic or lab directly for a cash-pay quote before the draw.

What the evidence actually supports, and what it does not

Established: spironolactone is FDA-approved for cardiovascular and renal indications, is not FDA-approved for acne, is not a controlled substance, and is available as an inexpensive generic. Compounding of patient-specific formulations through licensed 503A pharmacies is a legal, federally recognized pathway.

Plausible but not established at the same evidentiary level: that compounded topical spironolactone produces comparable acne outcomes to oral dosing. Oral anti-androgen therapy for adult female hormonal acne has been studied more extensively than topical compounded versions, and a full comparison requires checking current primary literature rather than relying on marketing claims from compounding-affiliated telehealth platforms.

Not established from the material available for this article: precise, current cash prices at specific Tennessee pharmacy chains, TennCare's exact current prior-authorization approval rate for acne indications, and the number of Tennessee marketplace plans covering spironolactone. These are volatile, payer- and pharmacy-specific facts that change over time and require direct verification rather than being cited as fixed figures.

Verification checklist: what is stable versus what you must re-check

Use this to distinguish stable information about spironolactone and acne treatment from details that require verification with each refill.

Stable, unlikely to change without a formal regulatory action

• Spironolactone's FDA-approved indications (heart failure, hypertension, edema, primary hyperaldosteronism), verify against the FDA approval record if in doubt.
• Acne and hirsutism are off-label uses, not FDA-approved indications.
• Spironolactone is not a DEA-controlled substance.
• The 503A versus 503B compounding framework and the general federal oversight structure, see FDA compounding Q&A.
• Baseline potassium and renal function monitoring is standard practice before and during therapy, especially with concurrent ACE inhibitors, ARBs, or potassium supplements.

Volatile, re-check before you rely on it

• Cash price at a specific Tennessee pharmacy for a specific dose and quantity today.
• Whether your specific commercial plan places generic spironolactone in a low copay tier this plan year, and whether the diagnosis code you submit affects that.
• TennCare's current formulary status and prior-authorization criteria for off-label dermatologic use, confirm directly at tn.gov/tenncare.
• Current discount-card pricing (GoodRx, SingleCare, mail-order pharmacies), which changes frequently and by location.
• A specific 503A compounding pharmacy's current price for a topical or capsule formulation.
• Whether a given telehealth platform requires baseline labs before or shortly after the first prescription; this is set by each practice, not by state law.

If a number in this article and a number you find at the pharmacy counter disagree, trust the pharmacy counter and your insurer's current documents, not this page.

When to seek care instead of managing this at home

Contact your prescriber promptly, rather than adjusting the dose yourself, if you develop muscle weakness, an irregular heartbeat, significant fatigue, or swelling while taking spironolactone, since these can be signs of elevated potassium. Seek urgent care for severe symptoms such as chest pain, fainting, or a very slow or irregular heartbeat. Spironolactone should not be started or continued without discussing current medications, kidney function, and pregnancy status with a licensed prescriber, since it carries specific contraindications and interaction risks that are individualized and cannot be resolved by a cost-focused article like this one.